Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

Our findings indicate that HMA/VEN combination therapy shows promise as a bridging strategy to allo-SCT in HR-MDS and CMML.

Authors

Institutions

Publication Details

Journal
Experimental Hematology and Oncology
Published
2025-04-26
DOI
https://doi.org/10.1186/s40164-025-00652-5
Citations
3
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
5.31

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

Inés Zugasti, Francesca Guijarro, Beatriz Merchán, Sandra Castaño‐Díez et al.
3 citations
Experimental Hematology and Oncology
Acute Myeloid Leukemia Research
5.31
article

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

Inés Zugasti, Francesca Guijarro, Beatriz Merchán, Sandra Castaño‐Díez, Mònica López‐Guerra, Carmen Martı́nez, Jordi Esteve, Irene Conejo, Lucie Salomon du Mont, Daniel Esteban, Esther Carcelero, Alexandra Martínez‐Roca, David Valcárcel, Gisela Riu-Viladoms, Cristina de la Fuente Montes, María Queralt Salas, Carlos Jiménez‐Vicente, Joan Bargay, Félix López Cadenas, Sara García-Ávila, Helena Pomares, Ana Triguero, Fernando Ramos, Alejandro Avendaño, María Díez‐Campelo, Blanca Xicoy, Marina Díaz‐Beyá, Francesc Fernández‐Avilés, José Álamo, Lurdes Zamora, María Suárez‐Lledó, Albert Cortés‐Bullich, Víctor Torrecillas, Ana Pérez, Montserrat Rovira, Montserrat Arnán
article en
3 citations

Abstract

Our findings indicate that HMA/VEN combination therapy shows promise as a bridging strategy to allo-SCT in HR-MDS and CMML.

Experimental Hematology and OncologyVol. 14(1)
Universitat Autònoma de Barcelona (ES), Hospital Son Llatzer (ES), Josep Carreras Leukaemia Research Institute (ES), Complejo Hospitalario de Salamanca (ES), Hospital Clínic de Barcelona (ES), Navarrabiomed (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Del Mar (ES), Fundació Clínic per a la Recerca Biomèdica (ES), Centro de Investigación Biomédica en Red de Cáncer (ES), Hospital Universitario de León (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Universitat de Barcelona (ES)
European Commission, Instituto de Salud Carlos III
Good health and well-being
Openalex Percentile: Top 5%
Acute Myeloid Leukemia Research
5.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.